RGX-121: AN INVESTIGATIONAL GENE THERAPY FOR THE TREATMENT OF NEURONOPATHIC MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): INTERIM ANALYSIS OF DATA FROM THE FIRST-IN-HUMAN STUDY

被引：0
|
作者：
Blair, D. R. [1 ,2 ]
Harmatz, P. [2 ]
Ficicioglu, C. [3 ]
Giugliani, R. [4 ]
Rajan, D. S. [5 ]
Hagood, J. [6 ]
Fiscella, M. [6 ]
Yang, L. [6 ]
Gilmor, M. [6 ]
Cho, Y. [6 ]
Mulatya, C. [6 ]
Phillips, D. [6 ]
Falabella, P. [6 ]
Pisani, L. [6 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] UCSF Benioff Childrens Hosp Oakland, Oakland, CA USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] HCPA, Porto Alegre, RS, Brazil
[5] Univ Pittsburgh, Pittsburgh, PA USA
[6] REGENXBIO Inc, Rockville, MD USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2024年 / 72卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
566
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [31] First in-human, intracisternal dosing of RGX-111, an investigational AAV gene therapy, for a 21-month-old child with mucopolysaccharidosis type I (MPS I): 3.5 year follow-up
    Wang, Raymond Y.
    Movsesyan, Nina
    Kan, Shih-hsin
    Beydoun, Tammam
    Taylor, Mery
    Chang, Richard C.
    Phillips, Dawn
    Burke, Jenna
    Gilmor, Michelle
    Cho, Yoonjin
    Falabella, Paulo
    Pisani, Laura
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [32] BMN 110 (Recombinant Human GALNS), an Investigational Enzyme Replacement Therapy for Mucopolysaccharidosis Type IVA (MPS IVA Or Morquio Syndrome), Promotes Type II Collagen Synthesis in MPS IVA Patients
    Lorget, Florence
    Lee, Sungwook
    Lau, Kelly
    Tsuruda, Laurie
    Hendriksz, Chris
    Jones, Simon
    Vellodi, Ashok
    Cheng, Sabrina
    Decker, Celeste
    O'Neill, Charles
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S44 - S44
  • [33] Current and Future Treatment of Mucopolysaccharidosis (MPS) Type II: Is Brain-Targeted Stem Cell Gene Therapy the Solution for This Devastating Disorder?
    Horgan, Claire
    Jones, Simon A.
    Bigger, Brian W.
    Wynn, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [34] DUODENAL MUCOSAL REGENERATION INDUCED BY ENDOSCOPIC PULSED ELECTRIC FIELD TREATMENT IMPROVES GLYCEMIC CONTROL IN PATIENTS WITH TYPE II DIABETES - INTERIM RESULTS FROM A FIRST-IN-HUMAN STUDY
    Sartoretto, Adrian
    O'Neal, David
    Holt, Bronte
    Napier-Flood, Fiona
    Rattan, Arti
    Yuan, Cheng Yi
    Cameron, Georgie
    Marinos, George
    Abu Dayyeh, Barham
    GASTROINTESTINAL ENDOSCOPY, 2023, 97 (06) : AB11 - AB12
  • [35] Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II - data from the Hunter Outcome Survey
    Burton, Barbara K.
    Guffon, Nathalie
    Roberts, Jane
    van der Ploeg, Ans T.
    Jones, Simon A.
    MOLECULAR GENETICS AND METABOLISM, 2010, 101 (2-3) : 123 - 129
  • [36] T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
    Doran, Stacey L.
    Stevanovic, Sanja
    Adhikary, Sabina
    Gartner, Jared J.
    Jia, Li
    Kwong, Mei Li M.
    Faquin, William C.
    Hewitt, Stephen M.
    Sherry, Richard M.
    Yang, James C.
    Rosenberg, Steven A.
    Hinrichs, Christian S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (30) : 2759 - +
  • [37] Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study
    Rajagopalan, Harith
    Cherrington, Alan D.
    Thompson, Christopher C.
    Kaplan, Lee M.
    Rubino, Francesco
    Mingrone, Geltrude
    Becerra, Pablo
    Rodriguez, Patricia
    Vignolo, Paulina
    Caplan, Jay
    Rodriguez, Leonardo
    Galvao Neto, Manoel P.
    DIABETES CARE, 2016, 39 (12) : 2254 - 2261
  • [38] Interim analysis of a phase 1/2 study of weekly intravenous DNL310 (brain-penetrant enzyme replacement therapy) in mucopolysaccharidosis type II
    Muenzer, Joseph
    Burton, Barbara K.
    Harmatz, Paul
    Rajan, Deepa
    Jones, Simon A.
    van den Hout, Hannerieke . J. P.
    Mitchell, John
    Meirelles, Katia
    Engmann, Natalie
    Scheller, Adam
    Caprihan, Rupa
    Bhalla, Akhil
    Hung, Tony
    Nachtigall, Jason
    Zubizarreta, Imanol
    Lu, Sam
    Zhu, Yuda
    Chin, Peter
    Troyer, Matt D.
    Ho, Carole
    Dong, Wei
    Model, Fabian
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [39] Hematopoietic stem cell gene therapy for mucopolysaccharidosis type I-Hurler syndrome (OTL-203): Interim skeletal, neurological and systemic outcomes from a phase I/II study
    Bernardo, Maria Ester M.
    Tucci, Francesca
    Consiglieri, Giulia
    Oficialdegui, Maria Luz Uria
    Fumagalli, Francesca
    De Pellegrin, Maurizio
    Cossutta, Matilde
    Filisetti, Chiara
    Manitto, Maria Pia
    Butera, Carla
    Dane, Giulia
    Camesasca, Chiara
    Parini, Rossella
    Riera, Mireia Del Toro
    de Heredia, Cristina Diaz
    Aiuti, Alessandro
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02) : 10 - 11
  • [40] Intracerebroventricular enzyme replacement therapy in patients with neuronopathic mucopolysaccharidosis type II: Final report of 5-year results from a Japanese open-label phase 1/2 study
    Seo, Joo-Hyun
    Kosuga, Motomichi
    Hamazaki, Takashi
    Shintaku, Haruo
    Okuyama, Torayuki
    MOLECULAR GENETICS AND METABOLISM, 2023, 140 (04)
12345